Connected Insulin Pens Market to Reach $4.5 Billion by 2030 with 17.2% CAGR The global Connected Insulin Pens market has experienced robust growth, expanding from $850 million in 2015 to $1.9 billion in 2022, reflecting a CAGR of 12.5%. Rising diabetes prevalence, government healthcare initiatives, and technological advancements in digital therapeutics have fueled this growth. North America contributed 48% of the global revenue in 2022, while Europe and Asia-Pacific accounted for 28% and 14% respectively, highlighting regional adoption disparities. Read Full Research Study: Connected Insulin Pens https://marketintelo.com/report/connected-insulin-pens-market